EPISODE · Dec 1, 2025 · 27 MIN
HER2 Evolution in Gastroesophageal Cancer: New Therapies and Optimized Outcomes
from Keeping Current CME
Learn which HER2-targeted therapies are being evaluated for the first-line treatment of gastroesophageal adenocarcinoma. Credit available for this activity expires: 11/27/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-evolution-gastroesophageal-cancer-new-therapies-and-2025a1000x2t?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
HER2 Evolution in Gastroesophageal Cancer: New Therapies and Optimized Outcomes
0:00
27:15
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 27 minutes long.
When was this Keeping Current CME episode published?
This episode was published on December 1, 2025.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!